Call 413.540.1234 to
schedule an appointment
CONCERN/EAP: 413.534.2625
Billing questions? Call: 413.540.1212
CRISIS: 413.733.6661

Child Development & Parenting: Infants (0-2)
Resources
Basic Information
Infant Development: How Your Baby Grows and MaturesInfant Parenting: Keeping Your Baby Healthy and HappyInfant Safety: Keeping Your Baby SafeInfant Enrichment: Stimulating Your Baby
More InformationLatest News
Fetal Growth, Maternal Anger Impact Infant RegulationInfants Know Real 'Baby Talk' When They Hear ItOpioid Crisis Means More Newborns With Hepatitis C, But Few Get TestedCCHD Newborn Screening May Detect Other DiseasesHealth Tip: Prevent Hand, Foot and Mouth DiseaseMultiple Anesthesia Exposures Affect Learning and AttentionHealth Tip: Milestones to Look for by Age 5Anesthesia Doesn't Seem to Harm Child's IQ: StudyHealth Tip: Prevent Poisoning at HomeHeath Tip; How to Introduce Your Child to PeanutsHealth Tip: When to See a Doctor for Cradle CapZika Infection After Birth May Require Long-Term Follow-UpRear-Facing Car Seats Protect Tots in Crashes From Behind: StudyBabies Given Certain Meds May Have Higher Odds for Allergies LaterHealth Tip: Which Car Seat Should Your Child Use?Baby Sitters, Relatives Often Unaware of SIDS RiskReading With Your Toddler Boosts More Than Just Language SkillsHealth Tip: Treat Diarrhea in Young BabiesNew Moms Still Wary of Exposing Infants to PeanutsHealth Tip: Use a High Chair SafelyPoison Prevention at HomeGenetic Heart Defects Rarely the Cause of SIDS, Research ShowsVaccine Exposure in First 23 Months Has No Adverse ImpactMechanical Heart Valve Approved for NewbornsMom's Immune System May Affect Baby's BrainVaccines Don't Weaken Babies' Immune Systems: StudyHealth Tip: Prevent Tooth Decay in BabiesPointers for Easier Potty TrainingHealth Tip: Make Sure Babies Eat RightGut Microbiota May Affect Vertical Transmission of Being OverweightHealth Tip: Protect Baby from Whooping CoughMany Parents in the Dark on When Kids Should First See a DentistStroke May Not Mean Language Loss for NewbornsCause of Sudden Unexpected Infant Deaths Shifts in the U.S.Babies Face Higher SIDS Risk in Certain StatesNICU Family Integrated Care Ups Infant, Parent OutcomesBabies With Normal Head Size Might Still Have Zika-Linked Brain DamageZika Tied to Rise in U.S. Birth Defects: CDCNutrients in Child's First 1,000 Days Key for NeurodevelopmentOpioid Epidemic Also Taking Toll on BabiesHome Visit Program Can Help Prevent Toddler ObesityHealth Tip: Succeed in Toilet TrainingNeurodevelopment Not Impacted by Glucocorticoids in PreemiesToo Many Babies Still Die Needlessly of SIDS, CDC Says16 Percent of Infants Receive Complementary Foods Too Early2013 to 2015 Infant Mortality Rate Varied by State and RaceHealth Tip: Health Tip: Prepare Your Child for the DentistMost U.S. Babies Start Solid Foods Too SoonSpecial Baby Formula Doesn't Seem to Prevent Type 1 DiabetesHealth Tip: Ways to Bond With Baby
Questions and AnswersLinks
Related Topics

Child & Adolescent Development: Overview
Childhood Mental Disorders and Illnesses
Parenting
Child Development & Parenting: Early (3-7)
Child Development & Parenting: Middle (8-11)

Practice Variation in Treatment for Bronchiolitis in Infants


HealthDay News
Updated: Nov 28th 2017

new article illustration

TUESDAY, Nov. 28, 2017 (HealthDay News) -- For infants with bronchiolitis, the use of evidence-based supportive therapies (EBSTs) varies by hospital site, according to a study published online Nov. 28 in Pediatrics.

Suzanne Schuh, M.D., from the Hospital for Sick Children in Toronto, and colleagues conducted a retrospective study involving previously health infants aged <12 months with bronchiolitis. Data were included for 3,725 infants.

The researchers found that 39 percent of the patients were hospitalized and 69.8 percent of those hospitalized received EBST. There was variation in EBST use by site (range, 6 to 99 percent; P < 0.001), but not by network (P = 0.2). Significant multivariable predictors included age (odds ratio [OR], 0.9), oxygen saturation (OR, 1.3), apnea (OR, 3.4), dehydration (OR, 3.2), nasal flaring/grunting (OR, 2.4), poor feeding (OR, 2.1), chest retractions (OR, 1.9), and respiratory rate (OR, 1.2). There was variation in pharmacotherapy and radiography use by network and site (P < 0.001), with intersite ranges from 2 to 79 percent and 1.6 to 81 percent, respectively. The multivariable OR for use of pharmacotherapy was 22.7 in Spain and Portugal, 11.5 in Canada, 6.8 in the United States, and 1.4 in the United Kingdom, compared with Australia and New Zealand.

"The hospital site was a source of variation in all study outcomes, and the network also predicted the use of pharmacotherapy and radiography," the authors write.

Abstract/Full Text (subscription or payment may be required)